Joincare Pharmaceutical Group Industry Co.,Ltd. (SHSE:600380) commences share repurchases on March 9, 2021, under the program mandated by the shareholders in the Extraordinary General Meeting held on February 25, 2021. As per the mandate, the company is authorized to repurchase up to CNY 700 million worth of class A shares. The shares will be repurchased at a price of not more than CNY 20 per share. The program will be funded out of the company's own funds or self-raised funds. The shares repurchased this time will be used to reduce the company's registered capital. The program will expire earlier of February 24, 2022 or when the maximum limit is reached, unless terminated by the Board earlier.